November 2008
Behind the headlines
NICE issues guidance on of erlotinib for the treatment of non-small-cell lung cancer
NICE has today published final guidance on the use of erlotinib for the treatment of non-small-cell lung cancer (NSCLC). The guidance recommends erlotinib as an alternative to docetaxel for people who have already tried one chemotherapy regimen but it has not worked.
NICE guidelines are set to improve the diagnosis and management of adults at risk of and with metastatic spinal cord compression
NICE has today published a clinical guideline on the diagnosis and management of adults at risk of and with metastatic spinal cord compression. Metastatic spinal cord compression is a rare complication of cancer.
Guidance this month
Clinical guidelines
Technology appraisals
- Lung cancer (non-small cell) - erlotinib
- Osteoporosis - primary prevention
- Osteoporosis - secondary prevention
Public health
- None
Interventional procedures
- Electrically-stimulated intravesical chemotherapy for superficial bladder cancer
- Laparoscopic prostatectomy for benign prostatic obstruction
- Transabdominal artificial bowel sphincter implantation for faecal incontinence
Helping you put NICE guidance into practice
For direct access to tools which help you to implement our guidance, subscribe to the Into Practice newsletter.
Events
Come and visit us at the 10th NICE annual conference:
NICE 2008: Excellence in action, 10th anniversary conference
3-4 December 2008
Manchester Central, Manchester
'NICE 2008: excellence in action', will focus firmly on the practical. The event will feature a range of 'real life' case studies on how to implement NICE guidance and what works in practice.
NICE 2008 will also feature key sessions on NICE's future roles under the new arrangements described by Lord Darzi and how they will impact upon all those working in health services.
Coming up next month
NICE expects to issue the following guidance on 17 December 2008:
Clinical guidelines
- None
Technology appraisals
Public health
- None